changes in [Ca"], whereas a voltage pulse produces very rapid changes of [Ca"] close to the membrane. In Figure 1 , however, values derived from ionomycin applications seem to indicate that for faster changes the dose-response curve should be extrapolated along the stippled curve. The value for secretion rates obtained during voltage pulses can be compared with this extrapolation to estimate the calcium level at the release site. A more quantitative value, however, can be obtained from the model of Heinemann et al. [17] in which Cadependent rates for the release process were derived from data as shown in Figure 1 , assuming a two-step process of vesicle supply into a releaseready pool (step 1) followed by the actual release (step 2). Assuming an initial size for the releaseready pool of 500 fF and secretion rates as derived from this model, it is seen that values for [Ca'+] of between 2 and 3.5 p M are required at the release site. This is about a factor of 10 higher than increments of average cellular calcium recorded with fura-2 during such stimulation. The experimental rates (100-500 fF) and the size of the readily-releasable pool (500 fF) also imply that depletion of that pool occurs within 1-5 s when the cell is depolarized or when [Ca2+] is increased by other experimental manipulations into the range of a few micromolar. Then, the overall reaction rate is no longer determined by the secretion process itself, but rather by the supply of new secretory granules.
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The small size of nerve terminals has ruled out the use of this type of approach at the vertebrate neuromuscular junction. However, evoked release (quanta1 content of the endplate potential) can be measured as a function of extracellular calcium concentration. Experiments have shown that, in muscle from mice with passively transferred LEMS, more calcium was required to produce equivalent acetylcholine secretion [7] . These results are compatible with an immune-mediated reduction in the number of functional calcium channels at the presynaptic terminal.
SCI,C cells also express calcium channels that are downregulated by LEMS IgG [S], providing a probable link between LEMS and cancer. An initial immune response is presumably directed against the tumour, and anti-calcium channel antibodies are produced that then cross-react with antigenically similar structures in synaptic terminals to produce the neurological syndrome. Most neurons express several types of voltage-dependent calcium channel which have been classified according to their electrophysiological and pharmacological properties [9, lo] . The first calcium channel to be characterized biochemically was the I,-type channel in skeletal muscle which was isolated as the receptor for the 1,4-dihydropyridine calcium channel antagonists. It has a hetero-oligomeric structure containing a I, a,-d, B and y subunits [ 111. The aI subunit alone forms the calcium-conducting transmembrane pore and binds calcium antagonist drugs and toxins, while the other subunits appear to play a regulatory role. Molecular cloning has allowed the primary structure of these polypeptides to be elucidated, and skeletal muscle a 1 probes have been used to isolate a family of homologous cDNAs from rat brain libraries [ 121.
Particularly useful tools for the study of neuronal calcium channels are the w conotoxins, a family of calcium-antagonist peptides isolated from the venoms of marine gastropods [ 131. N-type calcium channels, which play a major role in excitation-secretion coupling, can be labelled with ["'I] w-conotoxin GVIA ([ "'I] w-CgTx). The first biochemical assay for an anti-calcium channel antibody specificity in IXMS IgG was reported by Sher and collaborators [ 141. They demonstrated that N-type calcium channels, solubilized from human neuroblastoma membranes and labelled with [Ir51] w-CgTx, were specifically immunoprecipitated by E M S antibodies.
The aim of the research presented in this paper was to identify at a molecular level the LEMS antigen(s) associated with presynaptic N-type calcium channels. Our findings have some novel implications concerning the molecular mechanisms of synaptic vesicle docking at neurotransmitter release sites. Identification of the LEMS antigen A monoclonal antibody (mAb) has been produced that has strikingly similar properties to LEMS IgG.
Results and discussion
In an attempt to obtain antibodies directed against N-type calcium channels SJI, mice were immunized with chick brain synaptic membranes. Hybridomas were produced and screened for their ability to secrete antibodies that interact with [ 'Z'I]o-CgTx receptors, using a protocol analogous to the LEMS immunoprecipitation assay described above. In this way mAblD12 was generated. mAblD12 immuno-'
precipitates calcium channel and recognizes a 58 kDa band in immunoblots of rat brain synaptic membranes [ 201. Immunocytochemistry has shown the 1D12 antigen to be a fairly abundant constituent of synaptic regions of the central and peripheral nervous systems, that is present in both synaptic vesicles and plasma membrane [20] . In order to determine whether mAblD12 and LEMS antigen do indeed recognize the same protein, two complementary experiments were performed. Firstly, LEMS IgG and mAblD12 were used to probe Western blots of partially purified N-type calcium channel. Both labelled the same 58 kDa band. Secondly, 1D12 antigen was purified on a mAb 1D 12-Sepharose 4B immunoaffinity column. LEMS IgG was shown to bind to this protein (Figure l) , whereas healthy human IgG did not [ 151. The antigen in question was then identified by immunoscreening a rat brain Agtll library with mAb 1D12. Four overlapping clones were isolated, and the sequence obtained [15] was found to be virtually identical to nucleotides 577-2673 of synaptotagmin (p65), a synaptic vesicle membrane protein [21-251. The molecular properties of synaptotagmin suggest that it is involved in exocytosis. It contains an internally repeated cytoplasmic sequence homologous to the C2 region of protein kinase C [22] and binds calmodulin [23] . It interacts with acidic phospholipids [22, 241 and calcium ions, suggesting that it may be a calcium receptor for transmitter release [25] . Direct functional evidence for synaptotagmin's physiological role is lacking. Recent work has demonstrated that synaptotagmin-deficient subclones of the pheochromocytoma cell line PC12 display normal catecholamine secretion in response to potassium depolarization [26] . Neurosecretory cell lines, however, cannot be considered as a relevant model for all types of neurotransmitter release, and the question as to whether synaptotagmin is necessary for rapid synaptic transmission at the neuromuscular junction still remains open.
Discussion
The results outlined in this paper point to two major conclusions. Firstly, synaptotagmin associates with N-type calcium channels. The protein remains associated with such channels during an affinity fractionation procedure that results in approximately 300-fold purification. Furthermore, a [20] .
Membrane potential may conceivably play a role in docking as the calcium channel undergoes voltagedependent conformational transitions corresponding to gating. One can imagine that these transitions may mask and unmask binding sites for other proteins at the cytoplasmic face. A precedent for direct interaction between a voltage-gated calcium channel at the plasma membrane and proteins in an intracellular compartment exists in skeletal muscle where excitation-contraction coupling is mediated by interaction between the T-tubule dihydropyridine receptor and the sarcoplasmic reticulum release channel.
If the autoantibodies directed against synaptotagmin are pathogenic in LEMS they presumably bind to an extracellularly orientated epitope. Following calcium-triggered exocytosis, the intravesicular N-terminal domain of synaptotagmin would be exposed at the cell surface. Circulating LEMS antibodies could then bind to a synaptotagmin-calcium channel complex. Multiple synaptotagmin isoforms are expressed in the nervous system [ 30-321. Although the cytoplasmic domain is conserved, the N terminus, thought to bind LEMS IgG, is variable and glycosylated. An import- 
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ant aim at present is to identify the synaptotagmin epitope(s) that bind LEMS IgG, and to determine whether antibodies directed against this motif can induce calcium channel downregulation and inhibition of rapid synaptic release in an animal model.
